Harmony Biosciences (NASDAQ: HRMY) net income
Harmony Biosciences reported a net profit of $158.7m for fiscal 2025, 9.1% more than in fiscal 2024 ($145.5m). Its net margin was 18.3%. Earnings per share were $2.76.
Harmony Biosciences has grown its net income for 2 years in a row, and its best year of the last 7 was fiscal 2022. The biggest drop was in fiscal 2023, −29.0%. It reported a loss in 2 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $158.7m | +9.1% | 18.3% | $2.76 |
| 2024 | $145.5m | +12.9% | 20.4% | $2.56 |
| 2023 | $128.9m | −29.0% | 22.1% | $2.17 |
| 2022 | $181.5m | +424.5% | 41.4% | $3.07 |
| 2021 | $34.6m | — | 11.3% | $0.60 |
| 2020 | −$36.9m | — | −23.1% | −$2.48 |
| 2019 | −$152.0m | — | −2,535.1% | −$24.07 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Harmony Biosciences net income compared with its sector
By net income for its latest fiscal year, Harmony Biosciences ranks 101st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Harmony Biosciences, 18.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 99th | Pediatrix Medical Group | $165.4m | 8.6% |
| 100th | Cormedix | $163.1m | 52.3% |
| 101st | Harmony Biosciences | $158.7m | 18.3% |
| 102nd | Bausch Health Companies | $157.0m | 1.5% |
| 103rd | ADMA Biologics | $146.9m | 28.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Harmony Biosciences
- How much did Harmony Biosciences earn in fiscal 2025?
- Harmony Biosciences reported a net profit of $158.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $145.5m.
- What are the earnings per share of Harmony Biosciences?
- They were $2.76 in fiscal 2025, compared with $2.56 in fiscal 2024.
- What is the net margin of Harmony Biosciences?
- In fiscal 2025 its net profit was 18.3% of its revenue.
- What was the most profitable year for Harmony Biosciences?
- Of its last 7 fiscal years, fiscal 2022, with $181.5m.
- Where does Harmony Biosciences rank in its sector by net income?
- It ranks 101st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Harmony Biosciences come from?
- From the annual report (Form 10-K) that Harmony Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Harmony Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Harmony Biosciences: the Harmony Biosciences page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.